1. Esgueva, Raquel, Perner, Sven, J LaFargue, Christopher, Kristiansen, Glen, Rubin, Mark A. 2010. Prevalence of TMPRSS2-ERG and SLC45A3-ERG gene fusions in a large prostatectomy cohort. In Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc, 23, 539-46. doi:10.1038/modpathol.2009.193. https://pubmed.ncbi.nlm.nih.gov/20118910/
2. Perner, Sven, Rupp, Niels J, Braun, Martin, Stephan, Carsten, Kristiansen, Glen. 2012. Loss of SLC45A3 protein (prostein) expression in prostate cancer is associated with SLC45A3-ERG gene rearrangement and an unfavorable clinical course. In International journal of cancer, 132, 807-12. doi:10.1002/ijc.27733. https://pubmed.ncbi.nlm.nih.gov/22821757/
3. Qin, Fujun, Zhang, Yanmei, Liu, Jia, Li, Hui. 2017. SLC45A3-ELK4 functions as a long non-coding chimeric RNA. In Cancer letters, 404, 53-61. doi:10.1016/j.canlet.2017.07.007. https://pubmed.ncbi.nlm.nih.gov/28716526/
4. Sun, Jielin, Tao, Sha, Gao, Yong, Xu, Jianfeng, Mo, Zengnan. 2012. Genome-wide association study identified novel genetic variant on SLC45A3 gene associated with serum levels prostate-specific antigen (PSA) in a Chinese population. In Human genetics, 132, 423-9. doi:10.1007/s00439-012-1254-3. https://pubmed.ncbi.nlm.nih.gov/23269536/
智鼠故事 
